Safe and effective administration of BCG for bladder carcinoma in situ after umbilical cord blood stem cell transplantation.
Transpl Infect Dis
; 19(6)2017 Dec.
Article
em En
| MEDLINE
| ID: mdl-28796929
ABSTRACT
Although intravesical Bacillus Calmette-Guérin (BCG) instillation is the standard treatment for carcinoma in situ of the bladder, it is generally contraindicated in immunocompromised patients. Here we report the first case, to our knowledge, of BCG treatment for a bladder cancer patient who had received umbilical cord blood stem cell transplantation (UCBSCT). BCG can be given safely and effectively in select cases where reconstitution of the immune system has been achieved at least 2 years after UCBSCT.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias da Bexiga Urinária
/
Síndromes Mielodisplásicas
/
Vacina BCG
/
Carcinoma in Situ
/
Adjuvantes Imunológicos
/
Transplante de Células-Tronco de Sangue do Cordão Umbilical
Limite:
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2017
Tipo de documento:
Article